SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. Its lead product candidate, Bimatoprost Drug Pad-IOL System (BIM-IOL System), is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) for patients who have wither open-angel glaucoma (OAG) or ocular hypertension (OHT). The company was founded in January 2019 by Malik Y. Kahook and Glenn Sussman and is headquartered in Aliso Viejo, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of SpyGlass Pharma Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. SpyGlass Pharma Inc. market cap is $842.45M.
What is the 52-week high for SpyGlass Pharma Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. SpyGlass Pharma Inc. 52 week high is $32.44 as of February 08, 2026.
What is the 52-week low for SpyGlass Pharma Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. SpyGlass Pharma Inc. 52 week low is $16.00 as of February 08, 2026.
What is SpyGlass Pharma Inc. stock price today?
SpyGlass Pharma Inc. stock price today is $26.40.
What was SpyGlass Pharma Inc. stock price yesterday?
SpyGlass Pharma Inc. stock price yesterday was $16.00.
What is the Price-to-Book ratio of SpyGlass Pharma Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. SpyGlass Pharma Inc. P/B ratio is -13.9307.
What is the 50-day moving average of SpyGlass Pharma Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. SpyGlass Pharma Inc. 50-day moving average is $21.20.